Isbn: 9786209935633 - role of roflumilast among copd patients to prevent exacerbations: oral roflumilast as a new treatment modality for copd exacerbations (4 risultati)

- Brossura
Da: preigu, Osnabrück, Germaniapreigu
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 43,30
EUR 70,00 spedizioneSpedito da Germania a U.S.A.Quantità: 5 disponibili
Taschenbuch. Condizione: Neu. Role of Roflumilast Among COPD Patients to Prevent Exacerbations | Oral Roflumilast as a New Treatment Modality for COPD Exacerbations | Talha Laique (u. a.) | Taschenbuch | Englisch | 2026 | LAP LAMBERT Academic Publishing | EAN 9786209935633 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu.…

- Brossura
- Print on Demand
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 48,90
EUR 23,00 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 88 pp. Englisch.

- Brossura
- Print on Demand
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 49,49
EUR 35,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibile
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder and a major cause of morbidity and mortality worldwide, particularly in low- and middle-income countries such as Pakistan, where underdiagnosis and limited healthcare resources remain significant challenges. Despite standard therapies, frequent exacerbations continue to worsen patient outcomes and increase healthcare burden.Roflumilast, an oral phosphodiesterase-4 (PDE-4) inhibitor, has emerged as a promising new treatment option for severe COPD with recurrent exacerbations. This study evaluates the effectiveness and safety of oral roflumilast as an adjunct to standard therapy in preventing exacerbations and improving pulmonary function among COPD patients. …

- Brossura
- Print on Demand
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 48,90
EUR 60,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibile
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware 88 pp. Englisch.